Literature DB >> 15536466

Tumor-based pharmacokinetics has greater significance for anticancer drugs than does blood-based pharmacokinetics.

Walter Wolf, Cary A Presant.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15536466     DOI: 10.1016/j.clpt.2004.08.012

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Computational analysis of drug transport in tumor microenvironment as a critical compartment for nanotherapeutic pharmacokinetics.

Authors:  Arturas Ziemys; Steve Klemm; Miljan Milosevic; Kenji Yokoi; Mauro Ferrari; Milos Kojic
Journal:  Drug Deliv       Date:  2015-04-02       Impact factor: 6.419

Review 2.  Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells.

Authors:  Haifa Shen; Tong Sun; Hanh H Hoang; Jana S Burchfield; Gillian F Hamilton; Elizabeth A Mittendorf; Mauro Ferrari
Journal:  Semin Immunol       Date:  2017-09-23       Impact factor: 11.130

3.  Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier.

Authors:  Kenji Yokoi; Diana Chan; Milos Kojic; Miljan Milosevic; David Engler; Rise Matsunami; Tomonori Tanei; Yuki Saito; Mauro Ferrari; Arturas Ziemys
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

4.  Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance.

Authors:  A Ziemys; K Yokoi; M Kai; Y T Liu; M Kojic; V Simic; M Milosevic; A Holder; M Ferrari
Journal:  J Control Release       Date:  2018-10-14       Impact factor: 9.776

Review 5.  The Unique Pharmacometrics of Small Molecule Therapeutic Drug Tracer Imaging for Clinical Oncology.

Authors:  Mark P S Dunphy; Nagavarakishore Pillarsetty
Journal:  Cancers (Basel)       Date:  2020-09-22       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.